Early recognition and management of sepsis in adults: the first six hours.

Sepsis is a complication of severe infection characterized by a systemic inflammatory response. Mortality rates from sepsis range between 25% to 30% for severe sepsis and 40% to 70% for septic shock. The clinical presentation of sepsis is highly variable depending on the etiology. The most common sites of infection are the respiratory, genitourinary, and gastrointestinal systems, as well as the skin and soft tissue. Fever is often the first manifestation of sepsis, with pneumonia being the most common presentation leading to sepsis. Early goal-directed therapy completed within the first six hours of sepsis recognition significantly decreases in-hospital mortality. Initial management includes respiratory stabilization followed by aggressive fluid resuscitation. Vasopressor therapy is indicated when fluid resuscitation fails to restore adequate mean arterial pressure and organ perfusion. Early antibiotic therapy can improve clinical outcomes, and should be given within one hour of suspected sepsis. Blood product therapy may be required in some cases to correct coagulopathy and anemia, and to improve the central venous oxygen saturation. Insulin therapy may be required to maintain serum glucose levels less than 180 mg per dL. Initiation of low-dose corticosteroids may further improve survival in patients with septic shock that does not respond to vasopressor therapy. Timely initiation of evidence-based protocols should improve sepsis outcomes.

[1]  James A Russell,et al.  Management of sepsis. , 2006, The New England journal of medicine.

[2]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[3]  P. Pronovost,et al.  Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.

[4]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[5]  S. Dzik.  Early goal-directed therapy in the treatment of severe sepsis and septic shock , 2002 .

[6]  D. Cook,et al.  Crystalloids vs. colloids in fluid resuscitation: a systematic review. , 1999, Critical care medicine.

[7]  David T. Huang,et al.  Severe sepsis and septic shock: review of the literature and emergency department management guidelines. , 2006, Annals of emergency medicine.

[8]  Taka-aki Nakada,et al.  Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality* , 2011, Critical care medicine.

[9]  J. Vincent,et al.  Defining sepsis. , 2008, Clinics in chest medicine.

[10]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[11]  Anand Kumar,et al.  A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study , 2010, Critical care medicine.

[12]  Michael Baram,et al.  Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. , 2008, Chest.

[13]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[14]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[15]  Robyn Norton,et al.  A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .

[16]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[17]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[18]  R. Wunderink,et al.  Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study* , 2005, Critical care medicine.

[19]  E. J. Young,et al.  Manifestations of sepsis. , 1987, Archives of internal medicine.

[20]  Iain Mackenzie,et al.  Sepsis: definition, epidemiology, and diagnosis , 2007, BMJ : British Medical Journal.

[21]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[22]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[23]  R. Balk,et al.  SEVERE SEPSIS AND SEPTIC SHOCK , 2000 .

[24]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[25]  Pei-Chin Lin,et al.  The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: A meta-analysis , 2010, Critical care medicine.

[26]  S. Hollenberg.  Vasopressor support in septic shock. , 2007, Chest.

[27]  S. Zanotti-Cavazzoni,et al.  Before-after study of a standardized hospital order set for the management of septic shock , 2008 .

[28]  J. Mylotte,et al.  Epidemiology of bloodstream infection in nursing home residents: evaluation in a large cohort from multiple homes. , 2002, Clinical Infectious Diseases.

[29]  R. Munford,et al.  Novel therapies for septic shock over the past 4 decades. , 2011, JAMA.

[30]  Munish Goyal,et al.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department* , 2010, Critical care medicine.

[31]  T. Ahrens,et al.  Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation. , 2008, Critical care clinics.

[32]  Marc Moss,et al.  The effect of age on the development and outcome of adult sepsis* , 2006, Critical care medicine.

[33]  R. Cavallazzi,et al.  Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: A systematic review of the literature* , 2009, Critical care medicine.

[34]  O. Tanner.  Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .

[35]  D. Talan,et al.  Severe sepsis and septic shock in the emergency department. , 2008, Infectious disease clinics of North America.

[36]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[37]  S. Piper,et al.  Use of dopamine in acute renal failure. , 2002, Critical care medicine.

[38]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[39]  C. Koebnick,et al.  Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome* , 2002, Critical care medicine.

[40]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[41]  Jeffrey A. Kline,et al.  The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: A meta-analysis* , 2008, Critical care medicine.

[42]  B. Cunha.  Sepsis and septic shock: selection of empiric antimicrobial therapy. , 2008, Critical care clinics.

[43]  Robert Steele,et al.  Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality* , 2007, Critical care medicine.

[44]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.